| scholarly article | Q13442814 |
| P50 | author | Hong-Xin Niu | Q88728426 |
| P2093 | author name string | Yihua Chen | |
| Yue Shi | |||
| Hongying Li | |||
| Siqi Chen | |||
| Xiaoyu Wu | |||
| Dongdong Tang | |||
| Xiaoqiao Wang | |||
| Yaowei Zou | |||
| P2860 | cites work | Valsartan ameliorates podocyte loss in diabetic mice through the Notch pathway. | Q53145678 |
| Advanced oxidation protein products as a novel marker of oxidative stress in uremia | Q71324551 | ||
| Markers of oxidative protein damage in plasma and urine of type 2 diabetic patients | Q82617038 | ||
| Comment on Sharma. Mitochondrial Hormesis and Diabetic Complications. Diabetes 2015;64:663-672 | Q85942162 | ||
| Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial | Q95817860 | ||
| Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade | Q24311006 | ||
| Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials | Q24632223 | ||
| A Systems Biology Overview on Human Diabetic Nephropathy: From Genetic Susceptibility to Post-Transcriptional and Post-Translational Modifications | Q26769678 | ||
| Biochemistry and molecular cell biology of diabetic complications | Q28131781 | ||
| The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis | Q29616513 | ||
| Mitochondria, oxidative stress and cell death | Q29618996 | ||
| Mpv17 in mitochondria protects podocytes against mitochondrial dysfunction and apoptosis in vivo and in vitro | Q33701530 | ||
| Podocytes, signaling pathways, and vascular factors in diabetic kidney disease | Q33821237 | ||
| Prevention of diabetic nephropathy in Ins2(+/)⁻(AkitaJ) mice by the mitochondria-targeted therapy MitoQ. | Q34277437 | ||
| A mitochondrial superoxide theory for oxidative stress diseases and aging | Q35014145 | ||
| Mycophenolate mofetil and valsartan inhibit podocyte apoptosis in streptozotocin-induced diabetic rats | Q35026016 | ||
| Optimisation of an Advanced Oxidation Protein Products Assay: Its Application to Studies of Oxidative Stress in Diabetes Mellitus | Q35737933 | ||
| Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy | Q36319830 | ||
| Hypochlorite-Modified Albumin Upregulates ICAM-1 Expression via a MAPK-NF-κB Signaling Cascade: Protective Effects of Apocynin | Q36532079 | ||
| Mitochondria-targeted cytoprotective peptides for ischemia-reperfusion injury | Q36999928 | ||
| Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis | Q37166321 | ||
| Mechanisms of renal apoptosis in health and disease | Q37218601 | ||
| Diabetes and Kidney Disease: Role of Oxidative Stress | Q37349206 | ||
| Podocyte loss and progressive glomerular injury in type II diabetes | Q37362675 | ||
| Astragaloside IV Attenuates Podocyte Apoptosis Mediated by Endoplasmic Reticulum Stress through Upregulating Sarco/Endoplasmic Reticulum Ca2+-ATPase 2 Expression in Diabetic Nephropathy | Q37521278 | ||
| 2',7'-Dichlorodihydrofluorescein as a fluorescent probe for reactive oxygen species measurement: Forty years of application and controversy | Q37724866 | ||
| Oxidative stress, anti-oxidant therapies and chronic kidney disease. | Q37979867 | ||
| Olmesartan Prevents Microalbuminuria in db/db Diabetic Mice Through Inhibition of Angiotensin II/p38/SIRT1-Induced Podocyte Apoptosis | Q38729813 | ||
| Metformin modulates apoptosis and cell signaling of human podocytes under high glucose conditions. | Q38737184 | ||
| Role of mitochondrial dysfunction in renal fibrosis promoted by hypochlorite-modified albumin in a remnant kidney model and protective effects of antioxidant peptide SS-31. | Q38891120 | ||
| Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms. | Q38911994 | ||
| Smad3/Nox4-mediated mitochondrial dysfunction plays a crucial role in puromycin aminonucleoside-induced podocyte damage | Q38955832 | ||
| Mitochondria-targeted antioxidant peptide SS31 prevents hypoxia/reoxygenation-induced apoptosis by down-regulating p66Shc in renal tubular epithelial cells | Q39097729 | ||
| Regulation of podoplanin expression by microRNA-29b associates with its antiapoptotic effect in angiotensin II-induced injury of human podocytes. | Q40004766 | ||
| Accumulation of advanced oxidation protein products induces podocyte apoptosis and deletion through NADPH-dependent mechanisms | Q43281714 | ||
| Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway. | Q44528051 | ||
| Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury | Q44922430 | ||
| Total antioxidant status and markers of oxidative stress in subjects with normal or impaired glucose regulation (IFG, IGT) in diabetic patients | Q46060210 | ||
| Mitochondria-targeted peptide SS-31 attenuates renal injury via an antioxidant effect in diabetic nephropathy | Q46616439 | ||
| Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase | Q46823976 | ||
| Mitochondria-Targeted Antioxidant Peptide SS31 Protects Cultured Human Lens Epithelial Cells against Oxidative Stress | Q46826277 | ||
| Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy | Q46870214 | ||
| Advanced oxidative and glycoxidative protein damage markers in the elderly with type 2 diabetes. | Q46881644 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | mitochondrion | Q39572 |
| drug discovery | Q1418791 | ||
| P304 | page(s) | 394-404 | |
| P577 | publication date | 2019-12-01 | |
| P1433 | published in | Journal of Enzyme Inhibition and Medicinal Chemistry | Q15708877 |
| P1476 | title | A mitochondrial-targeted peptide ameliorated podocyte apoptosis through a HOCl-alb-enhanced and mitochondria-dependent signalling pathway in diabetic rats and in vitro | |
| P478 | volume | 34 |
| Q99619235 | Flavonoid compound breviscapine suppresses human osteosarcoma Saos-2 progression property and induces apoptosis by regulating mitochondria-dependent pathway |
| Q91690552 | Mitochondria-Targeted Peptide SS31 Attenuates Renal Tubulointerstitial Injury via Inhibiting Mitochondrial Fission in Diabetic Mice |
| Q97646299 | Research Progress on the Pathological Mechanisms of Podocytes in Diabetic Nephropathy |
| Q89896008 | The Role of PGC-1α and Mitochondrial Biogenesis in Kidney Diseases |
Search more.